As at Jan 14, 2025, the PROC stock has a PE ratio of 3.38. This is based on the current EPS of $0.52 and the stock price of $1.76 per share.
The mean historical PE ratio of Procaps Group over the last four years is 9.86. The current 3.38 PE ratio is 66% below the historical average. Over the past four years, PROC's PE ratio was at its highest in the Mar 2023 quarter at 14.09, with a price of $4.51 and an EPS of $0.32. The Jun 2023 quarter recorded the bottom point at 6.52, with a price of $4.3 and an EPS of $0.66.
Year | PE ratio | Change |
---|---|---|
2022 | 12.5 | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
PROC's current P/E ratio is below the 3 and 5-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
PROC Procaps Group SA | 3.38 | $198.57M |
OPTN OptiNose Inc | N/A | $52.59M |
OPK Opko Health Inc | N/A | $1B |
ORGO Organogenesis Holdings Inc | N/A | $401.71M |
As of Jan 14, 2025, PROC stock has a price to earnings ratio of 3.38.
As an average over the last 3 years, PROC stock has a PE ratio of 10.35.
As an average over the last 5 years, PROC stock has a PE ratio of 9.86.
In the last four years, the Mar 2023 quarter recorded the highest quarterly PE ratio at 14.09.
PROC's current price to earnings ratio is 66% below its 4-year historical average.
A company with a lower PE ratio may indicate that the market has lower growth expectations for the company's future earnings.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jan 14, 2025), Procaps Group's stock price is $1.76. The earnings per share for the trailing twelve months (TTM) ending Sep 2023 is $0.52. Therefore, Procaps Group's P/E ratio for today is 3.38. PE RATIO(3.38) = STOCK PRICE($1.76) / TTM EPS($0.52)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.